| 1 | Loeys-dietz syndrome | Enrichment | SMAD2, TGFB2, TGFB3, TGFBR1, TGFBR2 | 7.97 |
| 2 | Loeys-dietz syndrome 1 | Enrichment | SMAD2, TGFBR1, TGFBR2 | 6.03 |
| 3 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | SMAD2, SMAD4, TGFB2, TGFB3, TGFBR1, TGFBR2 | 5.37 |
| 4 | Robinow syndrome, autosomal dominant 1 | Enrichment | DVL1, FZD2, WNT5A | 5.33 |
| 5 | Autosomal dominant robinow syndrome | Enrichment | DVL1, FZD2, WNT5A | 5.33 |
| 6 | Heart disease | Enrichment | GATA4, MYL2, NKX2-5, TBX5 | 5.07 |
| 7 | Ventricular septal defect 1 | Enrichment | BMP2, BMP7, GATA4 | 5.03 |
| 8 | Robinow syndrome, autosomal recessive 1 | Enrichment | DVL1, FZD2, WNT5A | 4.94 |
| 9 | Ovarian cancer | Enrichment | AKT1, APC, BMPR1A, CTNNB1, HNF1A, HNF1B, NTRK1, PDGFRA | 4.93 |
| 10 | Atrial septal defect 1 | Enrichment | BMP2, TBX5, TGFB2 | 4.73 |
| 11 | Autosomal recessive robinow syndrome | Enrichment | DVL1, FZD2, WNT5A | 4.64 |
| 12 | Colorectal cancer | Enrichment | AKT1, APC, CTNNB1, FGFR2, FZD3, PIK3R1, SMAD4 | 4.42 |
| 13 | Type 2 diabetes mellitus | Enrichment | AKT2, HNF1A, HNF1B, HNF4A, TCF7L2 | 4.11 |
| 14 | Loeys-dietz syndrome 2 | Enrichment | TGFBR1, TGFBR2 | 4.01 |
| 15 | Fibrodysplasia ossificans progressiva | Enrichment | ACVR1, BMPR2 | 4.01 |
| 16 | Loeys-dietz syndrome 4 | Enrichment | TGFB2, TGFB3 | 4.01 |
| 17 | Hyperinsulinism due to hnf1a deficiency | Enrichment | HNF1A, HNF4A | 4.01 |
| 18 | Marfan syndrome | Enrichment | TGFB2, TGFBR1, TGFBR2 | 3.97 |
| 19 | Split hand-foot malformation | Enrichment | FGFR2, LEF1 | 3.95 |
| 20 | Desmoid disease, hereditary | Enrichment | APC, CTNNB1 | 3.54 |
| 21 | Juvenile polyposis syndrome | Enrichment | BMPR1A, SMAD4 | 3.54 |
| 22 | Osteoporosis, juvenile | Enrichment | DKK1, WNT3A | 3.54 |
| 23 | Transposition of the great arteries, dextro-looped | Enrichment | ACVR1B, BMP2 | 3.54 |
| 24 | Desmoid tumor | Enrichment | APC, CTNNB1 | 3.54 |
| 25 | Chromophobe renal cell carcinoma | Enrichment | HNF1A, HNF1B | 3.54 |
| 26 | Anastomosing haemangioma | Enrichment | GNA11, GNA14 | 3.54 |
| 27 | Pulmonary arterial hypertension associated with congenital heart disease | Enrichment | BMPR2, SMAD9 | 3.54 |
| 28 | Mullerian duct aplasia, unilateral renal agenesis, and cervicothoracic somite anomalies | Enrichment | HNF1B, WNT4 | 3.48 |
| 29 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | Enrichment | GNA11, PIK3R1 | 3.48 |
| 30 | Hydrocephalus | Enrichment | FGFR2, FZD3, PDGFRB | 3.31 |
| 31 | Brachydactyly, type a2 | Enrichment | BMP2, BMPR1B | 3.24 |
| 32 | Maturity-onset diabetes of the young, type 3 | Enrichment | HNF1A, HNF4A | 3.24 |
| 33 | Achromatopsia 4 | Enrichment | GNAI3, GNAT2 | 3.24 |
| 34 | Craniopharyngioma | Enrichment | APC, CTNNB1 | 3.24 |
| 35 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | AKT3, PIK3R2 | 3.18 |
| 36 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 | Enrichment | AKT3, PIK3R2 | 3.18 |
| 37 | Aortic aneurysm | Enrichment | SMAD3, TGFBR1 | 3.18 |
| 38 | Glioma | Enrichment | FGFR2, NTRK3 | 3.18 |
| 39 | Patent foramen ovale | Enrichment | GATA4, NKX2-5, TBX5 | 3.16 |
| 40 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1, FZD4 | 3.02 |
| 41 | Atrioventricular septal defect | Enrichment | BMP5, TBX5 | 3.02 |
| 42 | Robinow syndrome, autosomal dominant 2 | Enrichment | DVL1, FZD2 | 3.02 |
| 43 | Congenital heart defects, multiple types, 4 | Enrichment | BMP7, GATA4 | 3.02 |
| 44 | Fuchs' endothelial dystrophy | Enrichment | TCF4, ZEB1 | 3.02 |
| 45 | Generalized juvenile polyposis/juvenile polyposis coli | Enrichment | BMPR1A, SMAD4 | 3.02 |
| 46 | Maturity-onset diabetes of the young | Enrichment | HNF1A, HNF1B, HNF4A | 3.02 |
| 47 | Primary hypereosinophilic syndrome | Enrichment | PDGFRA, PDGFRB | 2.96 |
| 48 | Craniosynostosis | Enrichment | FGFR2, TCF12, TCF20 | 2.93 |
| 49 | Hepatocellular carcinoma | Enrichment | APC, AXIN1, CTNNB1 | 2.90 |
| 50 | Split-hand/foot malformation 1 | Enrichment | FGFR2, LEF1 | 2.79 |
| 51 | Familial atrial fibrillation | Enrichment | GATA4, NKX2-5, NPPA | 2.79 |
| 52 | Gallbladder cancer | Enrichment | CTNNB1, SMAD4 | 2.71 |
| 53 | Spastic paraplegia 4, autosomal dominant | Enrichment | GNAS, TCF4 | 2.58 |
| 54 | Exudative vitreoretinopathy | Enrichment | CTNNB1, FZD4 | 2.58 |
| 55 | Basal ganglia calcification, idiopathic, 1 | Enrichment | PDGFB, PDGFRB | 2.52 |
| 56 | Adult hepatocellular carcinoma | Enrichment | AXIN1, CTNNB1 | 2.48 |
| 57 | Autism spectrum disorder | Enrichment | GNB1, MEF2C, TCF12, TCF20, TCF4 | 2.35 |
| 58 | Autosomal non-syndromic agammaglobulinemia | Enrichment | PIK3R1, TCF3 | 2.32 |
| 59 | Left ventricular noncompaction | Enrichment | MYH7, MYH7B, NKX2-5 | 2.31 |
| 60 | Pectus excavatum | Enrichment | TCF20, TGFBR1 | 2.30 |
| 61 | Atrial heart septal defect | Enrichment | NKX2-5, TBX5 | 2.30 |
| 62 | Heritable pulmonary arterial hypertension | Enrichment | BMPR2, SMAD9 | 2.30 |
| 63 | Interatrial communication | Enrichment | NKX2-5, TBX5 | 2.30 |
| 64 | Epicanthus | Enrichment | ACVR1, TCF4 | 2.22 |
| 65 | Meningioma | Enrichment | AKT1, PDGFB | 2.16 |
| 66 | Dilated cardiomyopathy | Enrichment | MYH7, MYL2, NKX2-5, TBX5 | 2.09 |
| 67 | Medulloblastoma | Enrichment | APC, CTNNB1 | 2.09 |
| 68 | Breast cancer | Enrichment | AKT1, APC, GNG3, HNF1A | 2.08 |
| 69 | Hypertrophic cardiomyopathy | Enrichment | MYH7, MYH7B, MYL2 | 2.06 |
| 70 | Renal cell carcinoma, nonpapillary | Enrichment | HNF1A, HNF1B | 2.03 |
| 71 | Congenital myopathy 4a, autosomal dominant | Enrichment | MYH7, MYL2 | 2.03 |
| 72 | Cleft lip/palate | Enrichment | BMP4, PDGFRA | 2.03 |
| 73 | Chiari malformation type i | Enrichment | DKK1 | 2.01 |
| 74 | Hypocalciuric hypercalcemia, familial, type ii | Enrichment | GNA11 | 2.01 |
| 75 | Atrial septal defect 7 with or without atrioventricular conduction defects | Enrichment | NKX2-5 | 2.01 |
| 76 | Cardiospondylocarpofacial syndrome | Enrichment | MAP3K7 | 2.01 |
| 77 | Hepatic adenomas, familial | Enrichment | HNF1A | 2.01 |
| 78 | Nail disorder, nonsyndromic congenital, 1 | Enrichment | FZD6 | 2.01 |
| 79 | Stapes ankylosis with broad thumbs and toes | Enrichment | NOG | 2.01 |
| 80 | Tarsal-carpal coalition syndrome | Enrichment | NOG | 2.01 |
| 81 | Hypothyroidism, congenital, nongoitrous, 5 | Enrichment | NKX2-5 | 2.01 |
| 82 | Pseudohypoparathyroidism, type ic | Enrichment | GNAS | 2.01 |
| 83 | Polyposis syndrome, hereditary mixed, 2 | Enrichment | BMPR1A | 2.01 |
| 84 | Acromesomelic dysplasia 3 | Enrichment | BMPR1B | 2.01 |
| 85 | Holt-oram syndrome | Enrichment | TBX5 | 2.01 |
| 86 | Brachydactyly, type b2 | Enrichment | NOG | 2.01 |
| 87 | Osseous heteroplasia, progressive | Enrichment | GNAS | 2.01 |
| 88 | Omodysplasia 2 | Enrichment | FZD2 | 2.01 |
| 89 | Prostate cancer, hereditary, 11 | Enrichment | HNF1B | 2.01 |
| 90 | Multiple self-healing squamous epithelioma | Enrichment | TGFBR1 | 2.01 |
| 91 | Symphalangism, proximal, 1a | Enrichment | NOG | 2.01 |
| 92 | Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young | Enrichment | HNF4A | 2.01 |
| 93 | Caudal duplication anomaly | Enrichment | AXIN1 | 2.01 |
| 94 | Multiple synostoses syndrome 1 | Enrichment | NOG | 2.01 |
| 95 | Fetal encasement syndrome | Enrichment | CHUK | 2.01 |
| 96 | Neurodevelopmental disorder with involuntary movements | Enrichment | GNAO1 | 2.01 |
| 97 | Brachydactyly, type a1, d | Enrichment | BMPR1B | 2.01 |
| 98 | Frontometaphyseal dysplasia 2 | Enrichment | MAP3K7 | 2.01 |
| 99 | Atrioventricular septal defect 4 | Enrichment | GATA4 | 2.01 |
| 100 | Autoimmune lymphoproliferative syndrome, type iii | Enrichment | PRKCD | 2.01 |
| 101 | Ventricular tachycardia, familial | Enrichment | GNAI2 | 2.01 |
| 102 | Acth-independent macronodular adrenal hyperplasia 1 | Enrichment | GNAS | 2.01 |
| 103 | Ectodermal dysplasia 17 with or without limb malformations | Enrichment | LEF1 | 2.01 |
| 104 | Neurodevelopmental disorder with hypotonia and dysmorphic facies | Enrichment | GNB2 | 2.01 |
| 105 | Pituitary adenoma 3, multiple types | Enrichment | GNAS | 2.01 |
| 106 | Agammaglobulinemia 8b, autosomal recessive | Enrichment | TCF3 | 2.01 |
| 107 | Microphthalmia, syndromic 6 | Enrichment | BMP4 | 2.01 |
| 108 | Orofacial cleft 11 | Enrichment | BMP4 | 2.01 |
| 109 | Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language | Enrichment | MEF2C | 2.01 |
| 110 | Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities | Enrichment | GNAI1 | 2.01 |
| 111 | Developmental and epileptic encephalopathy 17 | Enrichment | GNAO1 | 2.01 |
| 112 | Agammaglobulinemia 8a, autosomal dominant | Enrichment | TCF3 | 2.01 |
| 113 | Lodder-merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia | Enrichment | GNB5 | 2.01 |
| 114 | Camurati-engelmann disease 2 | Enrichment | TGFB2 | 2.01 |
| 115 | Spinocerebellar ataxia 14 | Enrichment | PRKCG | 2.01 |
| 116 | Atrial septal defect 2 | Enrichment | GATA4 | 2.01 |
| 117 | Night blindness, congenital stationary, autosomal dominant 3 | Enrichment | GNAT1 | 2.01 |
| 118 | Colorectal cancer, hereditary nonpolyposis, type 6 | Enrichment | TGFBR2 | 2.01 |
| 119 | Ventricular septal defect 3 | Enrichment | NKX2-5 | 2.01 |
| 120 | Dystonia 25 | Enrichment | GNAL | 2.01 |
| 121 | Craniosynostosis 3 | Enrichment | TCF12 | 2.01 |
| 122 | Night blindness, congenital stationary, type 1g | Enrichment | GNAT1 | 2.01 |
| 123 | Hypocalcemia, autosomal dominant 2 | Enrichment | GNA11 | 2.01 |
| 124 | Pulmonary hypertension, primary, 2 | Enrichment | SMAD9 | 2.01 |
| 125 | Testicular anomalies with or without congenital heart disease | Enrichment | GATA4 | 2.01 |
| 126 | Loeys-dietz syndrome 6 | Enrichment | SMAD2 | 2.01 |
| 127 | Charcot-marie-tooth disease, dominant intermediate f | Enrichment | GNB4 | 2.01 |
| 128 | Microphthalmia/coloboma 11 | Enrichment | FZD5 | 2.01 |
| 129 | Type 1 diabetes mellitus 20 | Enrichment | HNF1A | 2.01 |
| 130 | Disorders of gnas inactivation | Enrichment | GNAS | 2.01 |
| 131 | Corneal dystrophy, fuchs endothelial, 3 | Enrichment | TCF4 | 2.01 |
| 132 | Hypoplastic left heart syndrome 2 | Enrichment | NKX2-5 | 2.01 |
| 133 | Congenital heart defects and ectodermal dysplasia | Enrichment | PRKD1 | 2.01 |
| 134 | Meier-gorlin syndrome 5 | Enrichment | CDC6 | 2.01 |
| 135 | Loeys-dietz syndrome 5 | Enrichment | TGFB3 | 2.01 |
| 136 | 20p12.3 microdeletion syndrome | Enrichment | BMP2 | 2.01 |
| 137 | 8p23.1 microdeletion syndrome | Enrichment | GATA4 | 2.01 |
| 138 | Intellectual developmental disorder, autosomal dominant 42 | Enrichment | GNB1 | 2.01 |
| 139 | Bartsocas-papas syndrome 2 | Enrichment | CHUK | 2.01 |
| 140 | Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 | Enrichment | BMP2 | 2.01 |
| 141 | Sick sinus syndrome 4 | Enrichment | GNB2 | 2.01 |
| 142 | Developmental delay with variable intellectual impairment and behavioral abnormalities | Enrichment | TCF20 | 2.01 |
| 143 | Craniometadiaphyseal osteosclerosis with hip dysplasia | Enrichment | AXIN1 | 2.01 |
| 144 | Trilateral retinoblastoma | Enrichment | RB1 | 2.01 |
| 145 | Congenital heart defects, multiple types, 8, with or without heterotaxy | Enrichment | SMAD2 | 2.01 |
| 146 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 2.01 |
| 147 | Heritable thoracic aortic disease | Enrichment | SMAD4 | 2.01 |
| 148 | Hyperinsulinism due to hnf4a deficiency | Enrichment | HNF4A | 2.01 |
| 149 | 5q14.3 microdeletion syndrome | Enrichment | MEF2C | 2.01 |
| 150 | Aortic arch interruption | Enrichment | NKX2-5 | 2.01 |
| 151 | Primary pulmonary hypertension | Enrichment | BMPR2 | 2.01 |
| 152 | Pulmonary hypertension | Enrichment | BMPR2 | 2.01 |
| 153 | Familial adenomatous polyposis | Enrichment | APC | 2.01 |
| 154 | Complete atrioventricular septal defect without ventricular hypoplasia | Enrichment | MEF2C | 2.01 |
| 155 | Drug- or toxin-induced pulmonary arterial hypertension | Enrichment | BMPR2 | 2.01 |
| 156 | Atrial heart septal defect 7 | Enrichment | NKX2-5 | 2.01 |
| 157 | Partial atrioventricular septal defect with ventricular hypoplasia | Enrichment | GATA4 | 2.01 |
| 158 | Combined immunodeficiency-hypogammaglobulinemia-skeletal anomalies syndrome due to ikbka deficiency | Enrichment | CHUK | 2.01 |
| 159 | Hypogonadotropic hypogonadism 26 with or without anosmia | Enrichment | TCF12 | 2.01 |
| 160 | Monostotic fibrous dysplasia | Enrichment | GNAS | 2.01 |
| 161 | Gardner syndrome | Enrichment | APC | 2.01 |
| 162 | Medullary sponge kidney | Enrichment | HNF1B | 2.01 |
| 163 | Gnao1-related disorder | Enrichment | GNAO1 | 2.01 |
| 164 | 5q22 microdeletion syndrome | Enrichment | APC | 2.01 |
| 165 | Mef2c-related disorder | Enrichment | MEF2C | 2.01 |
| 166 | Attenuated familial adenomatous polyposis | Enrichment | APC | 2.01 |
| 167 | Renal dysplasia, bilateral | Enrichment | HNF1B | 2.01 |
| 168 | Phakomatosis cesiomarmorata | Enrichment | GNA11 | 2.01 |
| 169 | Unilateral multicystic dysplastic kidney | Enrichment | HNF1B | 2.01 |
| 170 | Malignant epithelial tumor of salivary glands | Enrichment | PRKD1 | 2.01 |
| 171 | Kaposiform hemangioendothelioma | Enrichment | GNA14 | 2.01 |
| 172 | Renal dysplasia, unilateral | Enrichment | HNF1B | 2.01 |
| 173 | Mazabraud syndrome | Enrichment | GNAS | 2.01 |
| 174 | Microcystic stromal tumor | Enrichment | CTNNB1 | 2.01 |
| 175 | Lung oat cell carcinoma | Enrichment | RB1 | 2.01 |
| 176 | Gastric cancer | Enrichment | APC, FGFR2, SMAD4 | 1.97 |
| 177 | Proteus syndrome | Enrichment | AKT1 | 1.97 |
| 178 | Beare-stevenson cutis gyrata syndrome | Enrichment | FGFR2 | 1.97 |
| 179 | Mullerian aplasia and hyperandrogenism | Enrichment | WNT4 | 1.97 |
| 180 | Hypoinsulinemic hypoglycemia with hemihypertrophy | Enrichment | AKT2 | 1.97 |
| 181 | Premature aging syndrome, penttinen type | Enrichment | PDGFRB | 1.97 |
| 182 | Hypereosinophilic syndrome, idiopathic | Enrichment | PDGFRA | 1.97 |
| 183 | 46,xx sex reversal with dysgenesis of kidneys, adrenals, and lungs | Enrichment | WNT4 | 1.97 |
| 184 | Scaphocephaly, maxillary retrusion, and impaired intellectual development | Enrichment | FGFR2 | 1.97 |
| 185 | Apert syndrome | Enrichment | FGFR2 | 1.97 |
| 186 | Basal ganglia calcification, idiopathic, 5 | Enrichment | PDGFB | 1.97 |
| 187 | Split-hand/foot malformation 6 | Enrichment | WNT10B | 1.97 |
| 188 | Myofibromatosis, infantile, 1 | Enrichment | PDGFRB | 1.97 |
| 189 | Tooth agenesis, selective, 8 | Enrichment | WNT10B | 1.97 |
| 190 | Gist-plus syndrome | Enrichment | PDGFRA | 1.97 |
| 191 | Ataxia-oculomotor apraxia 3 | Enrichment | PIK3R5 | 1.97 |
| 192 | Bent bone dysplasia syndrome 1 | Enrichment | FGFR2 | 1.97 |
| 193 | Developmental and epileptic encephalopathy 58 | Enrichment | NTRK2 | 1.97 |
| 194 | Short syndrome | Enrichment | PIK3R1 | 1.97 |
| 195 | Diarrhea 9 | Enrichment | WNT2B | 1.97 |
| 196 | Deafness, autosomal recessive 68 | Enrichment | S1PR2 | 1.97 |
| 197 | Myeloid and lymphoid neoplasms associated with pdgfra rearrangement | Enrichment | PDGFRA | 1.97 |
| 198 | Bone mineral density quantitative trait locus 16 | Enrichment | WNT1 | 1.97 |
| 199 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 | Enrichment | AKT3 | 1.97 |
| 200 | Heterotaxy, visceral, 2, autosomal | Enrichment | CFC1 | 1.97 |
| 201 | Santos syndrome | Enrichment | WNT7A | 1.97 |
| 202 | Glaucoma 1, open angle, o | Enrichment | NTF4 | 1.97 |
| 203 | Basal ganglia calcification, idiopathic, 4 | Enrichment | PDGFRB | 1.97 |
| 204 | Immunodeficiency 36 with lymphoproliferation | Enrichment | PIK3R1 | 1.97 |
| 205 | Cowden syndrome 6 | Enrichment | AKT1 | 1.97 |
| 206 | Myeloid and lymphoid neoplasms associated with pdgfrb rearrangement | Enrichment | PDGFRB | 1.97 |
| 207 | Agammaglobulinemia 7, autosomal recessive | Enrichment | PIK3R1 | 1.97 |
| 208 | Obesity, hyperphagia, and developmental delay | Enrichment | NTRK2 | 1.97 |
| 209 | Kosaki overgrowth syndrome | Enrichment | PDGFRB | 1.97 |
| 210 | Ocular pterygium-digital keloid dysplasia syndrome | Enrichment | PDGFRB | 1.97 |
| 211 | Short-rib thoracic dysplasia 22 without polydactyly | Enrichment | FGF4 | 1.97 |
| 212 | Capillary hemangioma | Enrichment | AKT3 | 1.97 |
| 213 | Congenitally uncorrected transposition of the great arteries with coarctation | Enrichment | CFC1 | 1.97 |
| 214 | Biliary atresia with splenic malformation syndrome | Enrichment | CFC1 | 1.97 |
| 215 | Non-syndromic unicoronal craniosynostosis | Enrichment | FGFR2 | 1.97 |
| 216 | Congenitally uncorrected transposition of the great arteries with cardiac malformation | Enrichment | CFC1 | 1.97 |
| 217 | Akt2-related familial partial lipodystrophy | Enrichment | AKT2 | 1.97 |
| 218 | Cardiomyopathy, dilated, 1e | Enrichment | MYH7, MYL2 | 1.92 |
| 219 | Polycystic liver disease | Enrichment | CTNNB1, HNF4A | 1.92 |
| 220 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1, HNF4A | 1.92 |
| 221 | Heart, malformation of | Enrichment | GATA4, TBX5 | 1.87 |
| 222 | Ehlers-danlos syndrome | Enrichment | TGFB2, TGFBR2 | 1.83 |
| 223 | Hepatoblastoma | Enrichment | APC, CTNNB1 | 1.74 |
| 224 | Macs syndrome | Enrichment | SOX2, WNT7B | 1.73 |
| 225 | Tubulointerstitial kidney disease, autosomal dominant 1 | Enrichment | HNF1B | 1.71 |
| 226 | Ectrodactyly and ectodermal dysplasia without cleft lip/palate | Enrichment | LEF1 | 1.71 |
| 227 | Renal cysts and diabetes syndrome | Enrichment | HNF1B | 1.71 |
| 228 | Sveinsson chorioretinal atrophy | Enrichment | TEAD1 | 1.71 |
| 229 | Congenital anomalies of kidney and urinary tract 2 | Enrichment | HNF1B | 1.71 |
| 230 | Maturity-onset diabetes of the young, type 1 | Enrichment | HNF4A | 1.71 |
| 231 | Pseudohypoparathyroidism, type ia | Enrichment | GNAS | 1.71 |
| 232 | Myhre syndrome | Enrichment | SMAD4 | 1.71 |
| 233 | Camurati-engelmann disease 1 | Enrichment | TGFB1 | 1.71 |
| 234 | Pituitary adenoma 4, acth-secreting | Enrichment | GNAI2 | 1.71 |
| 235 | Cutis marmorata telangiectatica congenita | Enrichment | GNA11 | 1.71 |
| 236 | Thumb deformity | Enrichment | TBX5 | 1.71 |
| 237 | Ebstein anomaly | Enrichment | MYH7 | 1.71 |
| 238 | Pulmonary venoocclusive disease 1, autosomal dominant | Enrichment | BMPR2 | 1.71 |
| 239 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 1.71 |
| 240 | Pigmented nodular adrenocortical disease, primary, 1 | Enrichment | GNAS | 1.71 |
| 241 | Pseudopseudohypoparathyroidism | Enrichment | GNAS | 1.71 |
| 242 | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | Enrichment | SMAD4 | 1.71 |
| 243 | Microvascular complications of diabetes 5 | Enrichment | TGFBR2 | 1.71 |
| 244 | Atrial fibrillation, familial, 6 | Enrichment | NPPA | 1.71 |
| 245 | Robinow syndrome, autosomal dominant 3 | Enrichment | FZD2 | 1.71 |
| 246 | Chromosome 13q14 deletion syndrome | Enrichment | RB1 | 1.71 |
| 247 | Angioma, tufted | Enrichment | GNA14 | 1.71 |
| 248 | Night blindness, congenital stationary, type 1h | Enrichment | GNB3 | 1.71 |
| 249 | Heterotaxy, visceral, 4, autosomal | Enrichment | ACVR2B | 1.71 |
| 250 | Albinism, oculocutaneous, type ia | Enrichment | NOX4 | 1.71 |
| 251 | Inflammatory bowel disease, immunodeficiency, and encephalopathy | Enrichment | TGFB1 | 1.71 |
| 252 | Pulmonary venoocclusive disease 1 | Enrichment | BMPR2 | 1.71 |
| 253 | Hyperuricemic nephropathy, familial juvenile, 3 | Enrichment | HNF1B | 1.71 |
| 254 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 1.71 |
| 255 | Autosomal dominant hypocalcemia | Enrichment | GNA11 | 1.71 |
| 256 | Cardiomyopathy, familial hypertrophic, 10 | Enrichment | MYL2 | 1.71 |
| 257 | Pseudohypoparathyroidism | Enrichment | GNAS | 1.71 |
| 258 | Camurati-engelmann disease | Enrichment | TGFB1 | 1.71 |
| 259 | 46,xy sex reversal 3 | Enrichment | GATA4 | 1.71 |
| 260 | Periampullary adenoma | Enrichment | APC | 1.71 |
| 261 | Gastric adenocarcinoma and proximal polyposis of the stomach | Enrichment | APC | 1.71 |
| 262 | Aortic valve disease 2 | Enrichment | TBX5 | 1.71 |
| 263 | Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy | Enrichment | MYL2 | 1.71 |
| 264 | Hypopituitarism | Enrichment | GNAI2 | 1.71 |
| 265 | Lodder-merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia | Enrichment | GNB5 | 1.71 |
| 266 | Proximal symphalangism | Enrichment | NOG | 1.71 |
| 267 | Craniosynostosis 7 | Enrichment | BMP2 | 1.71 |
| 268 | Mitochondrial dna depletion syndrome 15 | Enrichment | TFAM | 1.71 |
| 269 | Hereditary mixed polyposis syndrome | Enrichment | BMPR1A | 1.71 |
| 270 | Familial isolated congenital asplenia | Enrichment | NKX2-5 | 1.71 |
| 271 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 1.71 |
| 272 | B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3) | Enrichment | TCF3 | 1.71 |
| 273 | Deletion 5q35 | Enrichment | NKX2-5 | 1.71 |
| 274 | Acth-independent macronodular adrenal hyperplasia | Enrichment | GNAS | 1.71 |
| 275 | Hyperinsulinism | Enrichment | HNF4A | 1.71 |
| 276 | Isolated atrial standstill | Enrichment | NPPA | 1.71 |
| 277 | Pulmonary venoocclusive disease | Enrichment | BMPR2 | 1.71 |
| 278 | Teratoma | Enrichment | CTNNB1 | 1.71 |
| 279 | Familial retinoblastoma | Enrichment | RB1 | 1.71 |
| 280 | B-lymphoblastic leukemia/lymphoma with t(17;19) | Enrichment | TCF3 | 1.71 |
| 281 | Juvenile polyposis of infancy | Enrichment | BMPR1A | 1.71 |
| 282 | Idiopathic/heritable pulmonary arterial hypertension | Enrichment | BMPR2 | 1.71 |
| 283 | Cerebral visual impairment | Enrichment | GNB1 | 1.71 |
| 284 | Phakomatosis cesioflammea | Enrichment | GNA11 | 1.71 |
| 285 | Attention deficit-hyperactivity disorder | Enrichment | GNB5, TCF20 | 1.71 |
| 286 | Visceral heterotaxy | Enrichment | ACVR2B, LEFTY2 | 1.71 |
| 287 | Myeloproliferative disorder, chronic, with eosinophilia | Enrichment | PDGFRB | 1.68 |
| 288 | Tooth agenesis, selective, 4 | Enrichment | WNT10A | 1.68 |
| 289 | Insensitivity to pain, congenital, with anhidrosis | Enrichment | NTRK1 | 1.68 |
| 290 | Schopf-schulz-passarge syndrome | Enrichment | WNT10A | 1.68 |
| 291 | Ulna and fibula, absence of, with severe limb deficiency | Enrichment | WNT7A | 1.68 |
| 292 | Bladder exstrophy and epispadias complex | Enrichment | WNT3 | 1.68 |
| 293 | Dermatofibrosarcoma protuberans | Enrichment | PDGFB | 1.68 |
| 294 | Odontoonychodermal dysplasia | Enrichment | WNT10A | 1.68 |
| 295 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | Enrichment | PIK3R5 | 1.68 |
| 296 | Tetraamelia syndrome 1 | Enrichment | WNT3 | 1.68 |
| 297 | Aural atresia, congenital | Enrichment | FGFR2 | 1.68 |
| 298 | Pfeiffer syndrome | Enrichment | FGFR2 | 1.68 |
| 299 | Osteogenesis imperfecta, type xv | Enrichment | WNT1 | 1.68 |
| 300 | Jackson-weiss syndrome | Enrichment | FGFR2 | 1.68 |
| 301 | Fibular aplasia or hypoplasia, femoral bowing, and poly-, syn-, and oligodactyly | Enrichment | WNT7A | 1.68 |
| 302 | Loeys-dietz syndrome 3 | Enrichment | SMAD3 | 1.68 |
| 303 | Pain sensitivity quantitative trait locus 1 | Enrichment | NTRK1 | 1.68 |
| 304 | Antley-bixler syndrome without genital anomalies or disordered steroidogenesis | Enrichment | FGFR2 | 1.68 |
| 305 | Infantile myofibromatosis | Enrichment | PDGFRB | 1.68 |
| 306 | Senior-loken syndrome 7 | Enrichment | AKT3 | 1.68 |
| 307 | Congenital mesoblastic nephroma | Enrichment | NTRK3 | 1.68 |
| 308 | Fibrosarcoma | Enrichment | NTRK3 | 1.68 |
| 309 | Bardet-biedl syndrome 16 | Enrichment | AKT3 | 1.68 |
| 310 | Autosomal dominant nonsyndromic deafness | Enrichment | FGFR2 | 1.68 |
| 311 | Chronic eosinophilic leukemia | Enrichment | PDGFRA | 1.68 |
| 312 | B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality | Enrichment | PDGFRA | 1.68 |
| 313 | Bladder exstrophy-epispadias-cloacal exstrophy complex | Enrichment | WNT3 | 1.68 |
| 314 | Congenital stationary night blindness | Enrichment | GNAT1, GNB3 | 1.67 |
| 315 | Microphthalmia | Enrichment | SOX2, WNT7B | 1.65 |
| 316 | Tooth agenesis | Enrichment | WNT10A, WNT10B | 1.65 |
| 317 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | MYH7, MYH7B | 1.63 |
| 318 | Pancreatic cancer | Enrichment | ACVR1B, SMAD4 | 1.60 |
| 319 | Tetralogy of fallot | Enrichment | GATA4, NKX2-5 | 1.57 |
| 320 | Brachydactyly, type a1 | Enrichment | BMPR1B | 1.53 |
| 321 | Mccune-albright syndrome | Enrichment | GNAS | 1.53 |
| 322 | Brachydactyly, type c | Enrichment | BMPR1B | 1.53 |
| 323 | Retinoblastoma | Enrichment | RB1 | 1.53 |
| 324 | Acromesomelic dysplasia 2a | Enrichment | BMPR1B | 1.53 |
| 325 | Acromesomelic dysplasia 2c | Enrichment | BMPR1B | 1.53 |
| 326 | Acromesomelic dysplasia 2b | Enrichment | BMPR1B | 1.53 |
| 327 | Cardiomyopathy, dilated, 1c, with or without left ventricular noncompaction | Enrichment | MYH7B | 1.53 |
| 328 | Osteogenic sarcoma | Enrichment | RB1 | 1.53 |
| 329 | Corneal dystrophy, posterior polymorphous, 3 | Enrichment | ZEB1 | 1.53 |
| 330 | Corneal dystrophy, fuchs endothelial, 6 | Enrichment | ZEB1 | 1.53 |
| 331 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 1.53 |
| 332 | Cenani-lenz syndactyly syndrome | Enrichment | APC | 1.53 |
| 333 | Woolly hair, autosomal recessive 3 | Enrichment | RB1 | 1.53 |
| 334 | Atrial standstill 2 | Enrichment | NPPA | 1.53 |
| 335 | Chromosome 17q12 deletion syndrome | Enrichment | HNF1B | 1.53 |
| 336 | Anus, imperforate | Enrichment | CTNNB1 | 1.53 |
| 337 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 1.53 |
| 338 | Keratoderma-ichthyosis-deafness syndrome, autosomal recessive | Enrichment | HNF1A | 1.53 |
| 339 | Hypotrichosis 8 | Enrichment | RB1 | 1.53 |
| 340 | Nail disease | Enrichment | FZD6 | 1.53 |
| 341 | Frontometaphyseal dysplasia | Enrichment | MAP3K7 | 1.53 |
| 342 | Squamous cell carcinoma | Enrichment | RB1 | 1.53 |
| 343 | Intraocular pressure quantitative trait locus | Enrichment | ZEB1 | 1.53 |
| 344 | Bone osteosarcoma | Enrichment | RB1 | 1.53 |
| 345 | Cushing syndrome due to bilateral macronodular adrenocortical disease | Enrichment | GNAS | 1.53 |
| 346 | Qualitative or quantitative defects of beta-myosin heavy chain | Enrichment | MYH7 | 1.53 |
| 347 | Idiopathic camptocormia | Enrichment | MYH7 | 1.53 |
| 348 | Colon adenocarcinoma | Enrichment | APC | 1.53 |
| 349 | Apc-associated polyposis conditions | Enrichment | APC | 1.53 |
| 350 | Crouzon syndrome | Enrichment | FGFR2 | 1.50 |
| 351 | Lacrimoauriculodentodigital syndrome 1 | Enrichment | FGFR2 | 1.50 |
| 352 | Thyroid carcinoma, familial medullary | Enrichment | NTRK1 | 1.50 |
| 353 | Microphthalmia, syndromic 9 | Enrichment | WNT7B | 1.50 |
| 354 | Tooth agenesis, selective, 2 | Enrichment | WNT10A | 1.50 |
| 355 | Immunodeficiency 14a with lymphoproliferation, autosomal dominant | Enrichment | PIK3R1 | 1.50 |
| 356 | Immunodeficiency 14 | Enrichment | PIK3R1 | 1.50 |
| 357 | Tetraamelia syndrome | Enrichment | WNT3 | 1.50 |
| 358 | Bladder cancer | Enrichment | CTNNB1, RB1 | 1.48 |
| 359 | Microcephaly | Enrichment | CTNNB1, GNAO1, GNB1, TCF4 | 1.47 |
| 360 | Differentiated thyroid carcinoma | Enrichment | NTRK1, NTRK3 | 1.42 |
| 361 | Myopathy, distal, 1 | Enrichment | MYH7 | 1.41 |
| 362 | Small cell cancer of the lung | Enrichment | RB1 | 1.41 |
| 363 | Congenital myopathy 7b, myosin storage, autosomal recessive | Enrichment | MYH7 | 1.41 |
| 364 | Spastic paraplegia 17, autosomal dominant | Enrichment | GNG3 | 1.41 |
| 365 | Pseudohypoparathyroidism, type ib | Enrichment | GNAS | 1.41 |
| 366 | Microtia-anotia | Enrichment | BMP5 | 1.41 |
| 367 | Auriculocondylar syndrome 1 | Enrichment | GNAI3 | 1.41 |
| 368 | Lipodystrophy, congenital generalized, type 2 | Enrichment | GNG3 | 1.41 |
| 369 | Pitt-hopkins syndrome | Enrichment | TCF4 | 1.41 |
| 370 | Pilomatrixoma | Enrichment | CTNNB1 | 1.41 |
| 371 | Congenital myopathy 7a, myosin storage, autosomal dominant | Enrichment | MYH7 | 1.41 |
| 372 | Lynch syndrome 4 | Enrichment | RB1 | 1.41 |
| 373 | Alazami syndrome | Enrichment | CTNNB1 | 1.41 |
| 374 | Multiple synostoses syndrome | Enrichment | NOG | 1.41 |
| 375 | Hyaline body myopathy | Enrichment | MYH7 | 1.41 |
| 376 | Hereditary ataxia | Enrichment | PRKCG | 1.41 |
| 377 | Retinopathy of prematurity | Enrichment | FZD4 | 1.41 |
| 378 | Corneal dystrophy | Enrichment | ZEB1 | 1.41 |
| 379 | Hereditary progressive cardiac conduction defect | Enrichment | NKX2-5 | 1.41 |
| 380 | Eyelid coloboma | Enrichment | FZD5 | 1.41 |
| 381 | Mitral valve insufficiency | Enrichment | TBX5 | 1.41 |
| 382 | Non-syndromic bicoronal craniosynostosis | Enrichment | TCF12 | 1.41 |
| 383 | Transposition of the great arteries | Enrichment | GATA4 | 1.41 |
| 384 | Clear cell papillary renal cell carcinoma | Enrichment | HNF1A | 1.41 |
| 385 | Lens coloboma | Enrichment | FZD5 | 1.41 |
| 386 | Familial sick sinus syndrome | Enrichment | GNB2 | 1.41 |
| 387 | Ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive | Enrichment | WNT10A | 1.38 |
| 388 | Microphthalmia, syndromic 3 | Enrichment | SOX2 | 1.38 |
| 389 | Saethre-chotzen syndrome | Enrichment | FGFR2 | 1.38 |
| 390 | Ectodermal dysplasia | Enrichment | WNT10A | 1.38 |
| 391 | Isolated congenitally uncorrected transposition of the great arteries | Enrichment | CFC1 | 1.38 |
| 392 | Inherited cancer-predisposing syndrome | Enrichment | APC, BMPR1A, RB1, SMAD4 | 1.38 |
| 393 | Familial hypertrophic cardiomyopathy | Enrichment | MYH7, MYL2 | 1.38 |
| 394 | Dystonia | Enrichment | GNAL, GNB1 | 1.33 |
| 395 | Capillary malformations, congenital | Enrichment | GNA11 | 1.31 |
| 396 | Arrhythmogenic right ventricular dysplasia, familial, 1 | Enrichment | TGFB3 | 1.31 |
| 397 | Congenital myopathy 3 with rigid spine | Enrichment | MYH7 | 1.31 |
| 398 | Norrie disease | Enrichment | FZD4 | 1.31 |
| 399 | Chondrosarcoma, extraskeletal myxoid | Enrichment | TCF12 | 1.31 |
| 400 | Night blindness, congenital stationary, type 1c | Enrichment | GNAT1 | 1.31 |
| 401 | Familial adenomatous polyposis 1 | Enrichment | APC | 1.31 |
| 402 | Cholangitis, primary sclerosing | Enrichment | TCF4 | 1.31 |
| 403 | Arrhythmogenic right ventricular dysplasia 1 | Enrichment | TGFB3 | 1.31 |
| 404 | Persistent hyperplastic primary vitreous | Enrichment | FZD4 | 1.31 |
| 405 | 2q23.1 microduplication syndrome | Enrichment | ACVR2A | 1.31 |
| 406 | Coloboma of choroid and retina | Enrichment | FZD5 | 1.31 |
| 407 | Persistent truncus arteriosus | Enrichment | NKX2-5 | 1.31 |
| 408 | Hemifacial hyperplasia | Enrichment | FGFR2 | 1.28 |
| 409 | Autosomal recessive hypohidrotic ectodermal dysplasia syndrome | Enrichment | WNT10A | 1.28 |
| 410 | Hemimegalencephaly | Enrichment | AKT3 | 1.28 |
| 411 | Melanoma, uveal | Enrichment | GNA11 | 1.24 |
| 412 | Coloboma of optic nerve | Enrichment | FZD5 | 1.24 |
| 413 | Corneal dystrophy, posterior polymorphous, 1 | Enrichment | ZEB1 | 1.24 |
| 414 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.24 |
| 415 | Conotruncal heart malformations | Enrichment | NKX2-5 | 1.24 |
| 416 | Type 1 diabetes mellitus | Enrichment | HNF1A | 1.24 |
| 417 | Anterior segment dysgenesis 5 | Enrichment | BMP4 | 1.24 |
| 418 | Inflammatory bowel disease 25, autosomal recessive | Enrichment | TGFB1 | 1.24 |
| 419 | Adrenocortical carcinoma | Enrichment | CTNNB1 | 1.24 |
| 420 | Clear cell renal cell carcinoma | Enrichment | HNF1A | 1.24 |
| 421 | Double outlet right ventricle | Enrichment | NKX2-5 | 1.24 |
| 422 | Il10-related early-onset inflammatory bowel disease | Enrichment | TGFB1 | 1.24 |
| 423 | Classic ehlers-danlos syndrome | Enrichment | TGFBR1 | 1.24 |
| 424 | Inherited arrhythmogenic cardiomyopathy | Enrichment | MYH7 | 1.24 |
| 425 | Multicystic kidney dysplasia | Enrichment | FZD3 | 1.24 |
| 426 | Multicystic dysplastic kidney | Enrichment | FZD3 | 1.24 |
| 427 | Renal dysplasia, cystic | Enrichment | WNT9B | 1.21 |
| 428 | Renal hypoplasia | Enrichment | WNT9B | 1.21 |
| 429 | Diarrhea | Enrichment | WNT2B | 1.21 |
| 430 | Breast adenocarcinoma | Enrichment | AKT1 | 1.21 |
| 431 | Cerebral palsy | Enrichment | GNB1, PDGFRB | 1.19 |
| 432 | Esophageal cancer | Enrichment | TGFBR2 | 1.17 |
| 433 | Hypothyroidism, congenital, nongoitrous, 2 | Enrichment | NKX2-5 | 1.17 |
| 434 | Coats disease | Enrichment | FZD4 | 1.17 |
| 435 | Brachydactyly | Enrichment | GNAS | 1.17 |
| 436 | Hereditary hemorrhagic telangiectasia | Enrichment | SMAD4 | 1.17 |
| 437 | Familial isolated restrictive cardiomyopathy | Enrichment | MYL2 | 1.17 |
| 438 | Gastrointestinal stromal tumor | Enrichment | PDGFRA | 1.14 |
| 439 | Neuropathy, hereditary sensory and autonomic, type v | Enrichment | NTRK1 | 1.14 |
| 440 | Pilomyxoid astrocytoma | Enrichment | NTRK2 | 1.14 |
| 441 | Megacolon | Enrichment | AKT3 | 1.14 |
| 442 | Overgrowth syndrome | Enrichment | PIK3R1 | 1.14 |
| 443 | Hemochromatosis, type 1 | Enrichment | BMP2 | 1.12 |
| 444 | Hypothyroidism | Enrichment | GNB1 | 1.12 |
| 445 | Myocarditis | Enrichment | MYH7 | 1.12 |
| 446 | Choreatic disease | Enrichment | GNAO1 | 1.12 |
| 447 | Hypoplastic left heart syndrome | Enrichment | NKX2-5 | 1.12 |
| 448 | West syndrome | Enrichment | GNAO1, NTRK2 | 1.10 |
| 449 | Hereditary breast carcinoma | Enrichment | AKT1, APC | 1.10 |
| 450 | Renal hypodysplasia/aplasia 1 | Enrichment | WNT9B | 1.09 |
| 451 | Isolated split hand-split foot malformation | Enrichment | WNT10B | 1.09 |
| 452 | Tooth agenesis, selective, 1 | Enrichment | BMPR2 | 1.07 |
| 453 | Cardiomyopathy, familial hypertrophic, 4 | Enrichment | MYH7 | 1.07 |
| 454 | Inflammatory bowel disease 1 | Enrichment | PRKCQ | 1.07 |
| 455 | Primary hyperaldosteronism | Enrichment | GNAS | 1.07 |
| 456 | Ventricular septal defect | Enrichment | TBX5 | 1.07 |
| 457 | Colonic benign neoplasm | Enrichment | APC | 1.07 |
| 458 | Familial isolated arrhythmogenic right ventricular dysplasia | Enrichment | MYH7 | 1.07 |
| 459 | Autosomal dominant non-syndromic intellectual disability | Enrichment | GNB1, TCF4 | 1.06 |
| 460 | Congenital nervous system abnormality | Enrichment | CTNNB1, GNAO1, GNB5 | 1.06 |
| 461 | Nervous system disease | Enrichment | CTNNB1, GNAO1, GNB5 | 1.06 |
| 462 | Cowden syndrome | Enrichment | AKT1 | 1.04 |
| 463 | Familial thoracic aortic aneurysm and dissection | Enrichment | SMAD3 | 1.04 |
| 464 | Renal agenesis, bilateral | Enrichment | WNT9B | 1.04 |
| 465 | Cat eye syndrome | Enrichment | FZD5 | 1.02 |
| 466 | Meier-gorlin syndrome 1 | Enrichment | CDC6 | 1.02 |
| 467 | Peters-plus syndrome | Enrichment | BMP4 | 1.02 |
| 468 | Stroke, ischemic | Enrichment | PRKCH | 1.02 |
| 469 | Stickler syndrome | Enrichment | BMP4 | 1.02 |
| 470 | Achromatopsia | Enrichment | GNAT2 | 1.02 |
| 471 | Polymicrogyria | Enrichment | AKT3 | 0.99 |
| 472 | Leukemia, acute lymphoblastic | Enrichment | GNB1 | 0.99 |
| 473 | Myelodysplastic syndrome | Enrichment | GNB1 | 0.99 |
| 474 | Movement disease | Enrichment | GNAO1 | 0.99 |
| 475 | Diabetes mellitus | Enrichment | HNF1A | 0.99 |
| 476 | Familial colorectal cancer type x | Enrichment | BMPR1A | 0.99 |
| 477 | Meningioma, familial | Enrichment | PDGFB | 0.96 |
| 478 | Nanophthalmos | Enrichment | SOX2 | 0.96 |
| 479 | Digeorge syndrome | Enrichment | HNF1A | 0.95 |
| 480 | Renal hypodysplasia/aplasia 3 | Enrichment | BMP4 | 0.95 |
| 481 | Restrictive cardiomyopathy | Enrichment | MYH7 | 0.95 |
| 482 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | TGFB3 | 0.95 |
| 483 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | TGFB3 | 0.95 |
| 484 | Lip and oral cavity carcinoma | Enrichment | RB1 | 0.95 |
| 485 | Myeloma, multiple | Enrichment | PIK3R2, TCF3 | 0.92 |
| 486 | Septooptic dysplasia | Enrichment | SOX2 | 0.92 |
| 487 | Aortic valve disease 1 | Enrichment | NKX2-5 | 0.92 |
| 488 | Microphthalmia/coloboma 12 | Enrichment | FZD5 | 0.92 |
| 489 | Pulmonary hypertension, primary, 1 | Enrichment | BMPR2 | 0.92 |
| 490 | Chromosome 1p36 deletion syndrome | Enrichment | PRKCZ | 0.92 |
| 491 | Stereotypic movement disorder | Enrichment | TCF4 | 0.92 |
| 492 | Complex neurodevelopmental disorder | Enrichment | GNB2, TCF20, TCF7L2 | 0.91 |
| 493 | Osteogenesis imperfecta, type iv | Enrichment | WNT1 | 0.89 |
| 494 | Chronic kidney disease | Enrichment | WNT9B | 0.89 |
| 495 | Cone-rod dystrophy 6 | Enrichment | GNAT2 | 0.89 |
| 496 | Aortic aneurysm, familial thoracic 1 | Enrichment | GATA4 | 0.89 |
| 497 | Lung cancer susceptibility 3 | Enrichment | RB1 | 0.89 |
| 498 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | TGFB3 | 0.89 |
| 499 | 46,xy partial gonadal dysgenesis | Enrichment | GATA4 | 0.89 |
| 500 | Coloboma of macula | Enrichment | FZD5 | 0.86 |
| 501 | Lynch syndrome | Enrichment | TGFBR2 | 0.86 |
| 502 | Rare genetic intellectual disability | Enrichment | GNAO1 | 0.86 |
| 503 | Septopreoptic holoprosencephaly | Enrichment | CRIPTO | 0.86 |
| 504 | Midline interhemispheric variant of holoprosencephaly | Enrichment | CRIPTO | 0.86 |
| 505 | Osteoporosis | Enrichment | WNT1 | 0.86 |
| 506 | Wolff-parkinson-white syndrome | Enrichment | MYH7 | 0.83 |
| 507 | Microform holoprosencephaly | Enrichment | CRIPTO | 0.83 |
| 508 | Lobar holoprosencephaly | Enrichment | CRIPTO | 0.83 |
| 509 | Osteogenesis imperfecta, type iii | Enrichment | WNT1 | 0.83 |
| 510 | Hypertension, essential | Enrichment | GNB3 | 0.81 |
| 511 | Cleft palate, isolated | Enrichment | GNB1 | 0.81 |
| 512 | Alobar holoprosencephaly | Enrichment | CRIPTO | 0.81 |
| 513 | Autism | Enrichment | TCF20, TCF7L2 | 0.80 |
| 514 | Neuromuscular disease | Enrichment | MYH7 | 0.79 |
| 515 | Early infantile developmental and epileptic encephalopathy | Enrichment | GNAO1 | 0.79 |
| 516 | Semilobar holoprosencephaly | Enrichment | CRIPTO | 0.79 |
| 517 | Dandy-walker syndrome | Enrichment | PDGFRB | 0.78 |
| 518 | Congenital myopathy | Enrichment | MYH7 | 0.76 |
| 519 | Endometrial cancer | Enrichment | FGFR2 | 0.70 |
| 520 | Cone dystrophy | Enrichment | GNAT2 | 0.67 |
| 521 | Brittle bone disorder | Enrichment | WNT1 | 0.66 |
| 522 | Developmental and epileptic encephalopathy 1 | Enrichment | GNAO1 | 0.66 |
| 523 | Hydrops fetalis, nonimmune | Enrichment | FZD6 | 0.64 |
| 524 | Strabismus | Enrichment | GNB1 | 0.63 |
| 525 | Prostate cancer | Enrichment | HNF1B | 0.60 |
| 526 | Long qt syndrome 1 | Enrichment | TBX5 | 0.59 |
| 527 | Non-immune hydrops fetalis | Enrichment | FZD6 | 0.58 |
| 528 | Cystic fibrosis | Enrichment | TGFB1 | 0.56 |
| 529 | Connective tissue disease | Enrichment | TGFBR2 | 0.56 |
| 530 | Cakut | Enrichment | HNF1B | 0.54 |
| 531 | Eye disease | Enrichment | GNAT2 | 0.53 |
| 532 | Developmental and epileptic encephalopathy | Enrichment | GNAO1 | 0.52 |
| 533 | Myopathy | Enrichment | MYH7 | 0.48 |
| 534 | Distal arthrogryposis | Enrichment | FZD3 | 0.47 |
| 535 | Thrombocytopenia | Enrichment | SMAD4 | 0.42 |
| 536 | Body mass index quantitative trait locus 11 | Enrichment | GNAS | 0.41 |
| 537 | Familial isolated dilated cardiomyopathy | Enrichment | MYH7 | 0.39 |
| 538 | Hypertelorism | Enrichment | FGFR2 | 0.37 |
| 539 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | GATA4 | 0.37 |
| 540 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | MEF2C | 0.36 |
| 541 | Undetermined early-onset epileptic encephalopathy | Enrichment | NTRK2 | 0.35 |
| 542 | Primary ovarian insufficiency | Enrichment | NTRK1 | 0.33 |
| 543 | Hereditary retinal dystrophy | Enrichment | FZD4, GNAT1, GNAT2 | 0.26 |
| 544 | Fundus dystrophy | Enrichment | FZD4, GNAT1, GNAT2 | 0.26 |
| 545 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | S1PR2 | 0.21 |
| 546 | Retinitis pigmentosa | Enrichment | GNAT1 | 0.06 |